Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
Loss of stromal fibroblast caveolin-1 (Cav-1) is a powerful single independent predictor of poor prognosis in human breast cancer patients, and is associated with early tumor recurrence, lymph node metastasis and tamoxifen-resistance. We developed a novel co-culture system to understand the mechanism(s) by which a loss of stromal fibroblast Cav-1 induces a "lethal tumor micro-environment." Here, we propose a new paradigm to explain the powerful prognostic value of stromal Cav-1. In this model, cancer cells induce oxidative stress in cancer-associated fibroblasts, which then acts as a "metabolic" and "mutagenic" motor to drive tumor-stroma co-evolution, DNA damage and aneuploidy in cancer cells. More specifically, we show that an acute loss of Cav-1 expression leads to mitochondrial dysfunction, oxidative stress and aerobic glycolysis in cancer associated fibroblasts. Also, we propose that defective mitochondria are removed from cancer-associated fibroblasts by autophagy/mitophagy that is induced by oxidative stress. As a consequence, cancer associated fibroblasts provide nutrients (such as lactate) to stimulate mitochondrial biogenesis and oxidative metabolism in adjacent cancer cells (the "Reverse Warburg Effect"). We provide evidence that oxidative stress in cancer-associated fibroblasts is sufficient to induce genomic instability in adjacent cancer cells, via a bystander effect, potentially increasing their aggressive behavior. Finally, we directly demonstrate that nitric oxide (NO) over-production, secondary to Cav-1 loss, is the root cause for mitochondrial dysfunction in cancer associated fibroblasts. In support of this notion, treatment with anti-oxidants (such as N-acetyl-cysteine, metformin and quercetin) or NO inhibitors (L-NAME) was sufficient to reverse many of the cancer-associated fibroblast phenotypes that we describe. Thus, cancer cells use "oxidative stress" in adjacent fibroblasts (i) as an "engine" to fuel their own survival via the stromal production of nutrients and (ii) to drive their own mutagenic evolution towards a more aggressive phenotype, by promoting genomic instability. We also present evidence that the "field effect" in cancer biology could also be related to the stromal production of ROS and NO species. eNOS-expressing fibroblasts have the ability to downregulate Cav-1 and induce mitochondrial dysfunction in adjacent fibroblasts that do not express eNOS. As such, the effects of stromal oxidative stress can be laterally propagated, amplified and are effectively "contagious"--spread from cell-to-cell like a virus--creating an "oncogenic/mutagenic" field promoting widespread DNA damage.
Martinez-Outschoorn
Ubaldo E
UE
Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Balliet
Renee M
RM
Rivadeneira
Dayana B
DB
Chiavarina
Barbara
B
Pavlides
Stephanos
S
Wang
Chenguang
C
Whitaker-Menezes
Diana
D
Daumer
Kristin M
KM
Lin
Zhao
Z
Witkiewicz
Agnieszka K
AK
Flomenberg
Neal
N
Howell
Anthony
A
Pestell
Richard G
RG
Knudsen
Erik S
ES
Sotgia
Federica
F
Lisanti
Michael P
MP
D001343:Autophagy; D005075:Biological Evolution; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism*; D051242:Caveolin 1 / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D018920:Coculture Techniques; D004249:DNA Damage; D015536:Down-Regulation; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D042822:Genomic Instability; D006657:Histones / Q000378:metabolism; D006801:Humans; D019344:Lactic Acid / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism / Q000502:physiology; D009569:Nitric Oxide / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D018384:Oxidative Stress; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism
D051242:Caveolin 1; D006657:Histones; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D009569:Nitric Oxide; D019344:Lactic Acid; D052250:Nitric Oxide Synthase Type III
Br J Pharmacol. 1992 Dec;107(4):1092-5
1281718
J Biol Chem. 1997 Oct 10;272(41):25437-40
9325253
J Biol Chem. 1997 Jun 27;272(26):16374-81
9195944
Cell. 2005 Feb 25;120(4):483-95
15734681
Nutr Cancer. 2002;43(1):59-66
12467136
Cancer Res. 2004 Aug 1;64(15):5148-53
15289318
Cancer Res. 2010 Jan 15;70(2):471-80
20068185
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20
9751731
Eur J Cancer. 2006 Oct;42(15):2653-9
16996262
Br J Cancer. 1996 Jan;73(2):189-96
8546905
J Clin Invest. 1996 Jul 15;98(2):345-51
8755643
J Natl Cancer Inst. 1998 Apr 15;90(8):587-96
9554441
J Bioenerg Biomembr. 2006 Feb;38(1):33-42
16732470
Genes Dev. 1998 Aug 1;12(15):2278-92
9694794
Mol Cell. 2004 Sep 10;15(5):767-76
15350220
Semin Cancer Biol. 2009 Feb;19(1):4-11
19101633
APMIS Suppl. 2003;(108):1-67
12874968
Cancer Biol Ther. 2010 Jul 15;10(2):135-43
20431349
Clin Cancer Res. 2006 Feb 15;12(4):1201-7
16489074
Nature. 2008 Mar 13;452(7184):230-3
18337823
Cancer Lett. 1994 Nov 25;87(1):115-20
7954364
DNA Repair (Amst). 2006 Jul 13;5(7):852-9
16781197
Am J Pathol. 2009 Jun;174(6):2035-43
19411449
J Immunol. 1997 Mar 1;158(5):2375-81
9036987
Am J Physiol Cell Physiol. 2001 Apr;280(4):C823-35
11245599
Am J Physiol Renal Physiol. 2002 Jul;283(1):F1-10
12060581
Am J Pathol. 2009 Mar;174(3):746-61
19234134
Nat Rev Cancer. 2006 May;6(5):392-401
16572188
J Biol Chem. 1996 Sep 20;271(38):23317-21
8798532
Clin Cancer Res. 2000 Jun;6(6):2408-16
10873093
Carcinogenesis. 2006 Feb;27(2):240-4
16162646
Med Hypotheses. 2001 Oct;57(4):497-502
11601878
Cancer Biol Ther. 2008 Aug;7(8):1212-25
18458534
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1381-5
7877987
Kidney Int. 2010 May;77(10):861-9
20164825
Biochim Biophys Acta. 2009 May;1787(5):462-7
19161973
Am J Pathol. 2009 Jun;174(6):2023-34
19411448
Rejuvenation Res. 2010 Apr-Jun;13(2-3):139-41
20370492
J Clin Invest. 2008 Dec;118(12):3930-42
19033663
Cancer Res. 2005 Apr 15;65(8):2997-3002
15833823
Free Radic Biol Med. 1994 Jun;16(6):811-20
8070685
Pathol Annu. 1971;6:1-59
4342307
Am J Surg Pathol. 1979 Dec;3(6):525-33
534389
J Nutr. 2007 Jan;137(1 Suppl):229S-232S
17182831
Ann Oncol. 1993 Sep;4(8):643-50
8240995
Diabetes Care. 2010 Jun;33(6):1304-8
20299480
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94
17726138
Int J Cancer. 2006 Jul 1;119(1):108-16
16450377
Cell Physiol Biochem. 1999;9(3):150-72
10494029
Oncol Rep. 2004 Oct;12(4):755-9
15375496
Prostate. 2009 Sep 15;69(13):1470-9
19462462
Cancer Res. 2006 Nov 1;66(21):10269-73
17062558
Cell Cycle. 2009 Dec;8(23):3984-4001
19923890
Med Hypotheses. 2010 Jul;75(1):26-31
20149555
Kidney Int. 2002 Mar;61(3):882-8
11849442
Cancer Cell. 2007 Sep;12(3):230-8
17785204
Cell Cycle. 2010 Jun 1;9(11):2201-19
20519932
Aging (Albany NY). 2010 Apr;2(4):185-99
20442453
Cancer Biol Ther. 2009 Jun;8(11):1071-9
19502809
Jpn J Cancer Res. 1997 Sep;88(9):861-6
9369934
Cell Cycle. 2009 Aug;8(15):2420-4
19556867
J Biol Chem. 2001 Oct 12;276(41):38121-38
11457855
Cancer. 2001 Oct 1;92(7):1807-17
11745253
J Cell Biochem. 2007 Jul 1;101(4):1038-45
17163455
Oncogene. 1998 Mar;16(11):1391-7
9525738
J Invest Dermatol. 1996 Mar;106(3):419-27
8648170
J Biol Chem. 1996 Nov 1;271(44):27237-40
8910295
Hum Mol Genet. 2004 Mar 15;13(6):659-67
14749350
AAPS J. 2008 Jun;10(2):311-21
18523892
Carcinogenesis. 2007 Jun;28(6):1247-53
17259657
Cancer Res. 2009 Oct 1;69(19):7507-11
19752085
Nat Med. 2005 Dec;11(12):1306-13
16286925
EMBO J. 1998 Nov 16;17(22):6633-48
9822607
Antioxid Redox Signal. 2008 Aug;10(8):1313-42
18435594
Clin Cancer Res. 2009 Jun 15;15(12):3979-89
19509179
Blood. 2001 Feb 15;97(4):1009-15
11159530
Free Radic Biol Med. 2000 Oct 15;29(8):695-703
11053770
Mol Pharmacol. 2000 Dec;58(6):1197-203
11093754
Fa Yi Xue Za Zhi. 2005 Aug;21(3):161-4
16259358
Breast Cancer Res Treat. 2002 Jun;74(3):271-8
12206516
Nat Genet. 1998 Feb;18(2):159-63
9462746
Biochemistry. 2001 Mar 20;40(11):3354-62
11258956
Cancer Res. 2008 Dec 1;68(23):9909-17
19047172
Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1005-28
11076791
Cell Cycle. 2010 Jun 15;9(12):2423-33
20562526
J Theor Biol. 2000 May 21;204(2):257-88
10887905